Literature DB >> 25303672

Guidelines on the management of AL amyloidosis.

Ashutosh D Wechalekar1, Julian D Gillmore, Jenny Bird, Jamie Cavenagh, Stephen Hawkins, Majid Kazmi, Helen J Lachmann, Philip N Hawkins, Guy Pratt.   

Abstract

Entities:  

Keywords:  AL amyloidosis; amyloid; chemotherapy; guidelines; transplantation

Mesh：

Year:  2014        PMID： 25303672     DOI： 10.1111/bjh.13155

Source DB:  PubMed          Journal:  Br J Haematol        ISSN： 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  26 in total

1.  ASNC/AHA/ASE/EANM/HFSA/ISA/SCMR/SNMMI expert consensus recommendations for multimodality imaging in cardiac amyloidosis: Part 1 of 2-evidence base and standardized methods of imaging.

Authors:  Sharmila Dorbala; Yukio Ando; Sabahat Bokhari; Angela Dispenzieri; Rodney H Falk; Victor A Ferrari; Marianna Fontana; Olivier Gheysens; Julian D Gillmore; Andor W J M Glaudemans; Mazen A Hanna; Bouke P C Hazenberg; Arnt V Kristen; Raymond Y Kwong; Mathew S Maurer; Giampaolo Merlini; Edward J Miller; James C Moon; Venkatesh L Murthy; C Cristina Quarta; Claudio Rapezzi; Frederick L Ruberg; Sanjiv J Shah; Riemer H J A Slart; Hein J Verberne; Jamieson M Bourque
Journal:  J Nucl Cardiol       Date:  2019-12       Impact factor: 5.952

2.  Amyloidosis: an unusual cause of upper gastrointestinal bleeding.

Authors:  Keith Siau; Amera Elzubeir; Sheldon C Cooper; Tariq Iqbal
Journal:  BMJ Case Rep       Date:  2016-10-26

Review 3.  New developments in diagnosis, risk assessment and management in systemic amyloidosis.

Authors:  Iuliana Vaxman; Angela Dispenzieri; Eli Muchtar; Morie Gertz
Journal:  Blood Rev       Date:  2019-11-02       Impact factor: 8.250

4.  Surgical management of macroglossia secondary to amyloidosis.

Authors:  Yusuf Gadiwalla; Richard Burnham; Adrian Warfield; Prav Praveen
Journal:  BMJ Case Rep       Date:  2016-04-11

5.  Rapid hematologic responses improve outcomes in patients with very advanced (stage IIIb) cardiac immunoglobulin light chain amyloidosis.

Authors:  Richa Manwani; Darren Foard; Shameem Mahmood; Sajitha Sachchithanantham; Thirusha Lane; Cristina Quarta; Taryn Youngstein; Tamer Rezk; Helen J Lachmann; Julian D Gillmore; Marianna Fontana; Carol Whelan; Philip N Hawkins; Ashutosh Wechalekar
Journal:  Haematologica       Date:  2018-01-05       Impact factor: 9.941

Review 6.  The Clinical Presentation and Management of Systemic Light-Chain Amyloidosis in China.

Authors:  Xiang-Hua Huang; Zhi-Hong Liu
Journal:  Kidney Dis (Basel)       Date:  2016-02-25

7.  First-in-Human Phase I/II Study of NEOD001 in Patients With Light Chain Amyloidosis and Persistent Organ Dysfunction.

Authors:  Morie A Gertz; Heather Landau; Raymond L Comenzo; David Seldin; Brendan Weiss; Jeffrey Zonder; Giampaolo Merlini; Stefan Schönland; Jackie Walling; Gene G Kinney; Martin Koller; Dale B Schenk; Spencer D Guthrie; Michaela Liedtke
Journal:  J Clin Oncol       Date:  2016-02-08       Impact factor: 44.544

Review 8.  Illustrative review of cardiac amyloidosis by multimodality imaging.

Authors:  Hidekazu Tanaka
Journal:  Heart Fail Rev       Date:  2022-04-26       Impact factor: 4.214

9.  Multisystem amyloidosis as the unifying diagnosis for constipation, collapse and cardiomyopathy.

Authors:  Michael McFarlane; Alexander Bashford; Shatrughan Sah; Ben R Disney
Journal:  BMJ Case Rep       Date:  2018-07-10

10.  Epidemiology of AL amyloidosis: a real-world study using US claims data.

Authors:  Tiffany P Quock; Tingjian Yan; Eunice Chang; Spencer Guthrie; Michael S Broder
Journal:  Blood Adv       Date:  2018-05-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.